The original success of Viagra undeniably revolutionized the drug landscape, but investing in companies heavily reliant on unbranded versions presents a uncertain picture. While early earnings were impressive, the cessation of patents and the emergence of discounted alternatives have eroded market share. Thus, a thorough assessment of present finan